Literature DB >> 14616789

Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.

R E Weir1, P E M Fine, B Nazareth, S Floyd, G F Black, E King, C Stanley, L Bliss, K Branson, H M Dockrell.   

Abstract

The immune responses of schoolchildren in southeast England to Mycobacterium tuberculosis and other species of mycobacteria were studied prior to vaccination with bacille Calmette-Guérin (BCG). Data are presented for tuberculin (Heaf) skin test and interferon-gamma (IFN-gamma) responses to M. tuberculosis purified protein derivative (PPD), and IFN-gamma responses to PPDs from eight other environmental mycobacteria, measured in 424 schoolchildren (13-15 years of age). Responses to M. tuberculosis PPD were detected in 27% of schoolchildren by in vitro IFN-gamma response and in 20% by the Heaf test. IFN-gamma responses were more prevalent to PPDs from species of mycobacteria other than M. tuberculosis, predominantly those of the MAIS complex and M. marinum (45-60% responders). Heaf test and IFN-gamma responses were associated (P<0.001) for M. tuberculosis, MAIS and M. marinum. These findings have implications for appropriate implementation of vaccination against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616789      PMCID: PMC1808851          DOI: 10.1046/j.1365-2249.2003.02272

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

Authors:  L A van Pinxteren; P Ravn; E M Agger; J Pollock; P Andersen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi.

Authors:  G F Black; D K Warndorff; S Floyd; R E Weir; J M Blackwell; L Bliss; L Sichali; L Mwaungulu; S Chaguluka; E Jarman; B Ngwira; H M Dockrell
Journal:  Int J Tuberc Lung Dis       Date:  2001-07       Impact factor: 2.373

3.  Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi.

Authors:  G F Black; H M Dockrell; A C Crampin; S Floyd; R E Weir; L Bliss; L Sichali; L Mwaungulu; H Kanyongoloka; B Ngwira; D K Warndorff; P E Fine
Journal:  J Infect Dis       Date:  2001-07-10       Impact factor: 5.226

4.  Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection.

Authors:  J A Streeton; N Desem; S L Jones
Journal:  Int J Tuberc Lung Dis       Date:  1998-06       Impact factor: 2.373

5.  Whole blood cytokine assays--a new generation of diagnostic tests for tuberculosis?

Authors:  H M Dockrell; R E Weir
Journal:  Int J Tuberc Lung Dis       Date:  1998-06       Impact factor: 2.373

6.  A longitudinal study of environmental mycobacteria on a farm in south-west England.

Authors:  H D Donoghue; E Overend; J L Stanford
Journal:  J Appl Microbiol       Date:  1997-01       Impact factor: 3.772

7.  Characterization of Mycobacterium avium complex related mycobacteria isolated from an African environment and patients with AIDS.

Authors:  P A Fonteyne; Z M Kunze; H De Beenhouwer; J M Dumonceau; D J Dawson; J J McFadden; F Portaels
Journal:  Trop Med Int Health       Date:  1997-02       Impact factor: 2.622

8.  Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity.

Authors:  F G Cobelens; H van Deutekom; I W Draayer-Jansen; A C Schepp-Beelen; P J van Gerven; R P van Kessel; M E Mensen
Journal:  Lancet       Date:  2000-08-05       Impact factor: 79.321

9.  Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon.

Authors:  R E Tascon; E Stavropoulos; K V Lukacs; M J Colston
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

10.  Opportunist mycobacteria in England and Wales: 1982 to 1994.

Authors:  K Lamden; J M Watson; G Knerer; M J Ryan; P A Jenkins
Journal:  Commun Dis Rep CDR Rev       Date:  1996-10-11
View more
  16 in total

1.  Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.

Authors:  Karen A Heemstra; Ailko W J Bossink; Roan Spermon; John J M Bouwman; Robert van der Kieft; Steven F T Thijsen
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

2.  Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-alpha and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis.

Authors:  Saet-Byel Jung; Chang-Hwa Song; Chul-Su Yang; Su-Young Kim; Kil-Soo Lee; A-Rum Shin; Ji-Sook Lee; Hae Sung Nam; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Eun-Kyeong Jo
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

Review 3.  Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Authors:  C Sander; H McShane
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.

Authors:  R E Weir; G F Black; B Nazareth; S Floyd; S Stenson; C Stanley; K Branson; L Sichali; S D Chaguluka; L Donovan; A C Crampin; P E M Fine; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

5.  Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection.

Authors:  S M B Jeronimo; A K B Holst; S E Jamieson; R Francis; D R A Martins; F L Bezerra; N A Ettinger; E T Nascimento; G R Monteiro; H G Lacerda; E N Miller; H J Cordell; P Duggal; T H Beaty; J M Blackwell; M E Wilson
Journal:  Genes Immun       Date:  2007-08-23       Impact factor: 2.676

6.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

7.  Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom.

Authors:  Rosemary E Weir; Gillian F Black; Hazel M Dockrell; Sian Floyd; Paul E M Fine; Steven D Chaguluka; Sally Stenson; Elizabeth King; Bernadette Nazareth; David K Warndorff; Bagrey Ngwira; Amelia C Crampin; Lorren Mwaungulu; Lifted Sichali; Elizabeth Jarman; Linda Donovan; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy.

Authors:  Maeve K Lalor; Anne Ben-Smith; Patricia Gorak-Stolinska; Rosemary E Weir; Sian Floyd; Rose Blitz; Hazzie Mvula; Melanie J Newport; Keith Branson; Nuala McGrath; Amelia C Crampin; Paul E M Fine; Hazel M Dockrell
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

9.  Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes.

Authors:  Cecilia S Lindestam Arlehamn; Sinu Paul; Federico Mele; Charlie Huang; Jason A Greenbaum; Randi Vita; John Sidney; Bjoern Peters; Federica Sallusto; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

10.  Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.

Authors:  Anna M Checkley; David H Wyllie; Thomas J Scriba; Tanya Golubchik; Adrian V S Hill; Willem A Hanekom; Helen McShane
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.